Cost per patient of treatment for rifampicin-resistant tuberculosis in a community-based programme in Khayelitsha, South Africa

Impact of reduced hospitalisation on the cost of treatment for drug-resistant tuberculosis in South Africa

(2015) E. Sinanovic et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Impact of Decentralized Care and the Xpert MTB/RIF Test on Rifampicin-Resistant Tuberculosis Treatment Initiation in Khayelitsha, South Africa

(2015) H. S. Cox et al.   Open Forum Infectious Diseases

Extensive Drug Resistance Acquired During Treatment of Multidrug-Resistant Tuberculosis

(2014) J. Peter Cegielski et al.   CLINICAL INFECTIOUS DISEASES

Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa

(2014) H. Cox et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline

(2014) Andreas H. Diacon et al.   NEW ENGLAND JOURNAL OF MEDICINE

What is the Cost of Diagnosis and Management of Drug Resistant Tuberculosis in South Africa?

(2013) Anil Pooran et al.   PLoS One

Delamanid for Multidrug-Resistant Pulmonary Tuberculosis

(2012) Maria Tarcela Gler et al.   NEW ENGLAND JOURNAL OF MEDICINE

Costs of inpatient treatment for multi-drug-resistant tuberculosis in South Africa

(2012) Kathryn Schnippel et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Mutations in the rrs A1401G Gene and Phenotypic Resistance to Amikacin and Capreomycin in Mycobacterium tuberculosis

(2011) Frederick A. Sirgel et al.   Microbial Drug Resistance

A Systematic Review of the Cost and Cost Effectiveness of Treatment for Multidrug-Resistant Tuberculosis

(2011) Christopher Fitzpatrick et al.   PHARMACOECONOMICS

Epidemic Levels of Drug Resistant Tuberculosis (MDR and XDR-TB) in a High HIV Prevalence Setting in Khayelitsha, South Africa

(2010) Helen S. Cox et al.   PLoS One